122 related articles for article (PubMed ID: 12381078)
1. Modification of treatment strategies over a period of 14 years has markedly reduced cardiac events among post-myocardial infarction patients.
Ishikawa K; Kimura A; Taniwa T; Takenaka T; Hayashi T; Kanamasa K;
Circ J; 2002 Oct; 66(10):881-5. PubMed ID: 12381078
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic therapies after myocardial infarction.
Rapaport E; Gheorghiade M
Am J Med; 1996 Oct; 101(4A):4A61S-69S; discussion 4A69S-70S. PubMed ID: 8900339
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Haim M; Gottlieb S; Boyko V; Reicher-Reiss H; Hod H; Kaplinsky E; Mandelzweig L; Goldbourt U; Behar S
Am Heart J; 1998 Aug; 136(2):245-51. PubMed ID: 9704685
[TBL] [Abstract][Full Text] [Related]
4. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
[TBL] [Abstract][Full Text] [Related]
5. Changing Trends in the Landscape of Patients Hospitalized With Acute Myocardial Infarction (2001 to 2011) (from the Worcester Heart Attack Study).
Mercado-Lubo R; Yarzebski J; Lessard D; Gore J; Goldberg RJ
Am J Cardiol; 2020 Mar; 125(5):673-677. PubMed ID: 31924320
[TBL] [Abstract][Full Text] [Related]
6. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
[TBL] [Abstract][Full Text] [Related]
7. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
Barron HV; Michaels AD; Maynard C; Every NR
J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
[TBL] [Abstract][Full Text] [Related]
8. Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants.
Becker RC; Burns M; Gore JM; Spencer FA; Ball SP; French W; Lambrew C; Bowlby L; Hilbe J; Rogers WJ
Am Heart J; 1998 May; 135(5 Pt 1):786-96. PubMed ID: 9588407
[TBL] [Abstract][Full Text] [Related]
9. [Two year follow-up of acute ischemic syndrome without ST elevation].
Tan HQ; Zhu J; Liang Y; Zhang Y; Liu LS;
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):184-8. PubMed ID: 15854465
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
Noll G; Kaufmann U; Wenzel RR; Lüscher TF
Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of patients with ischemic heart disease and diabetes].
Zaliūnas R; Babarskiene MR; Brazdzionyte J
Medicina (Kaunas); 2004; 40(2):192-7. PubMed ID: 15007279
[TBL] [Abstract][Full Text] [Related]
12. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic angiotensin converting enzyme inhibitor therapy on myocardial injury in patients undergoing percutaneous coronary interventions.
Aleti S; Bansal D; Agrawal M; Uretsky BF; Sachdeva R
J Invasive Cardiol; 2011 Feb; 23(2):72-5. PubMed ID: 21297204
[TBL] [Abstract][Full Text] [Related]
14. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
[TBL] [Abstract][Full Text] [Related]
15. [Survival after myocardial infarction in the nineties. Results of a prospective registry and their implications as to identification of an increased risk of death and especially sudden death].
Jordaens L; Tavernier R
J Med Liban; 1999; 47(3):181-9. PubMed ID: 10550944
[No Abstract] [Full Text] [Related]
16. The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES).
Kjøller-Hansen L; Steffensen R; Grande P
J Am Coll Cardiol; 2000 Mar; 35(4):881-8. PubMed ID: 10732883
[TBL] [Abstract][Full Text] [Related]
17. Trends in acute myocardial infarction treatment between 1998 and 2007 in a Belgian area (Charleroi).
Collart P; Coppieters Y; Levêque A
Eur J Prev Cardiol; 2012 Aug; 19(4):738-45. PubMed ID: 21708835
[TBL] [Abstract][Full Text] [Related]
18. Multidecade-long trends (1986-2005) in the utilization of coronary reperfusion and revascularization treatment strategies in patients hospitalized with acute myocardial infarction: a community-wide perspective.
Wasser J; Goldberg RJ; Spencer FA; Yarzebski J; Gore JM
Coron Artery Dis; 2009 Jan; 20(1):71-80. PubMed ID: 19050597
[TBL] [Abstract][Full Text] [Related]
19. Three-year follow-up of patients with silent ischemia in the subacute phase of myocardial infarction after thrombolysis and early coronary intervention.
Lotze U; Ozbek C; Gerk U; Kaufmann H; Sen S; Figulla HR
Int J Cardiol; 1999 Oct; 71(2):167-78. PubMed ID: 10574402
[TBL] [Abstract][Full Text] [Related]
20. Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based Recommendations.
Fitchett DH; Goodman SG; Leiter LA; Lin P; Welsh R; Stone J; Grégoire J; Mcfarlane P; Langer A
Can J Cardiol; 2016 Jul; 32(7 Suppl):S15-34. PubMed ID: 27342696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
